Literature DB >> 27679742

Small mammalian animal models of heart disease.

Paula Camacho1, Huimin Fan2, Zhongmin Liu2, Jia-Qiang He1.   

Abstract

There is an urgent clinical need to develop new therapeutic approaches for treating cardiovascular disease, but the biology of cardiovascular regeneration is complex. Model systems are required to advance our understanding of the pathogenesis, progression, and mechanisms underlying cardiovascular disease as well as to test therapeutic approaches to regenerate tissue and restore cardiac function following injury. An ideal model system should be inexpensive, easily manipulated, reproducible, physiologically representative of human disease, and ethically sound. The choice of animal model needs to be considered carefully since it affects experimental outcomes and whether findings of the study can be reasonably translated to humans. This review presents a guideline for the commonly used small animal models (mice, rats, rabbits, and cats) used in cardiac research as an effort to standardize the most relevant procedures and obtain translatable and reproducible results.

Entities:  

Keywords:  Mouse; cat; diabetic cardiomyopathy; heart failure; myocardial infarction; rabbit; rat

Year:  2016        PMID: 27679742      PMCID: PMC5030387     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  43 in total

1.  Identification of Nogo as a novel indicator of heart failure.

Authors:  Tara A Bullard; Tricia L Protack; Frédérick Aguilar; Suveer Bagwe; H Todd Massey; Burns C Blaxall
Journal:  Physiol Genomics       Date:  2007-10-30       Impact factor: 3.107

2.  Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD.

Authors:  C E Murry; M A Kay; T Bartosek; S D Hauschka; S M Schwartz
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

3.  Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit).

Authors:  Masashi Shiomi; Takashi Ito; Satoshi Yamada; Seinosuke Kawashima; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-08       Impact factor: 8.311

4.  Ascending aortic constriction in rats for creation of pressure overload cardiac hypertrophy model.

Authors:  Ajith Kumar Gs; Binil Raj; Kumar S Santhosh; G Sanjay; Chandrasekharan Cheranellore Kartha
Journal:  J Vis Exp       Date:  2014-06-29       Impact factor: 1.355

5.  Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury.

Authors:  Thomas E Robey; Charles E Murry
Journal:  Cardiovasc Pathol       Date:  2007-03-21       Impact factor: 2.185

6.  Effects of the alpha2-adrenergic/DA2-dopaminergic agonist CHF-1024 in preventing ventricular arrhythmogenesis and myocyte electrical remodeling, in a rat model of pressure-overload cardiac hypertrophy.

Authors:  Roberta Berni; Francesca Cacciani; Massimiliano Zaniboni; Monia Savi; Leonardo Bocchi; Silvia Lapucci; Roberta Razzetti; Fiorella Pastore; Ezio Musso; Donatella Stilli
Journal:  J Cardiovasc Pharmacol       Date:  2006-02       Impact factor: 3.105

7.  Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.

Authors:  Suzanne E Berry; Peter Andruszkiewicz; Ju Lan Chun; Jun Hong
Journal:  Stem Cells Transl Med       Date:  2013-09-25       Impact factor: 6.940

8.  Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats.

Authors:  Luisa M G de Macedo Braga; Kaleizu Rosa; Bruno Rodrigues; Christiane Malfitano; Melissa Camassola; Pedro Chagastelles; Silvia Lacchini; Patricia Fiorino; Kátia De Angelis; Beatriz D'Agord Schaan; Maria C Irigoyen; Nance Beyer Nardi
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-10-31       Impact factor: 2.557

9.  Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus.

Authors:  Magdi M El-Omar; Zhao-Kang Yang; Aled O Phillips; Ajay M Shah
Journal:  Basic Res Cardiol       Date:  2003-10-07       Impact factor: 17.165

10.  Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.

Authors:  Willem J de Lange; Adrian C Grimes; Laura F Hegge; J Carter Ralphe
Journal:  J Gen Physiol       Date:  2013-01       Impact factor: 4.086

View more
  59 in total

Review 1.  Drugs' development in acute heart failure: what went wrong?

Authors:  Vincenzo Teneggi; Nithy Sivakumar; Deborah Chen; Alex Matter
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

3.  Evaluation of telomere length in human cardiac tissues using cardiac quantitative FISH.

Authors:  Maryam Sharifi-Sanjani; Alan K Meeker; Foteini Mourkioti
Journal:  Nat Protoc       Date:  2017-08-17       Impact factor: 13.491

Review 4.  Childhood adversity and mechanistic links to hypertension risk in adulthood.

Authors:  Ijeoma E Obi; Kasi C McPherson; Jennifer S Pollock
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

5.  Different paths, same destination: divergent action potential responses produce conserved cardiac fight-or-flight response in mouse and rabbit hearts.

Authors:  Lianguo Wang; Stefano Morotti; Srinivas Tapa; Samantha D Francis Stuart; Yanyan Jiang; Zhen Wang; Rachel C Myles; Kieran E Brack; G André Ng; Donald M Bers; Eleonora Grandi; Crystal M Ripplinger
Journal:  J Physiol       Date:  2019-07-11       Impact factor: 5.182

6.  Myocardial-specific ablation of Jumonji and AT-rich interaction domain-containing 2 (Jarid2) leads to dilated cardiomyopathy in mice.

Authors:  Eunjin Cho; HyunJun Kang; Dae-Ki Kang; Youngsook Lee
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

Review 7.  Inherited cardiomyopathies in veterinary medicine.

Authors:  Joshua A Stern; Yu Ueda
Journal:  Pflugers Arch       Date:  2018-10-03       Impact factor: 3.657

8.  MYBPC3 Haplotype Linked to Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca mulatta).

Authors:  Robert F Oldt; Kimberly J Bussey; Matthew L Settles; Joseph N Fass; Jeffrey A Roberts; J Rachel Reader; Srivathsan Komandoor; Victor A Abrich; Sreetharan Kanthaswamy
Journal:  Comp Med       Date:  2020-08-04       Impact factor: 0.982

Review 9.  Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

Authors:  Houman Savoji; Mohammad Hossein Mohammadi; Naimeh Rafatian; Masood Khaksar Toroghi; Erika Yan Wang; Yimu Zhao; Anastasia Korolj; Samad Ahadian; Milica Radisic
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

Review 10.  Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Authors:  Kristin Wilson; Crystal Faelan; Janet C Patterson-Kane; Daniel G Rudmann; Steven A Moore; Diane Frank; Jay Charleston; Jon Tinsley; G David Young; Anthony J Milici
Journal:  Toxicol Pathol       Date:  2017-10-03       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.